Hospital services

Yale New Haven will offer hospital services to patients at home

NEW HAVEN – A new program to provide hospital care to patients at home was launched this week by Yale New Haven Health.

Yale New Haven has contracted with a private company, Medically Home, to provide the service, which will be available to Medicare patients who live within 25 miles of Yale New Haven or Bridgeport hospitals, according to a statement.

The program is expected to expand to other Yale New Haven hospitals in the future. Patients must meet clinical and social stability criteria to participate.

“Many patients prefer to be cared for at home,” Dr. Olukemi Akande, Chief Medical Officer, Post-Acute Care, said in the statement. “With the growth of telehealth and other mobile health technologies, we can provide a high level of care and 24/7 accessibility to these patients.”

Akande will co-lead the program with Dr. Scott Sussman, Physician Executive Director of Telehealth.

“Just as telehealth has transformed ambulatory care, it is helping us rethink the way we provide inpatient care,” Sussman said in the statement. “We can provide the same high-quality care in patients’ homes, reduce the risk of hospital-related complications and improve our patients’ experience by caring for them in a familiar environment.

Patients will participate in the program for an average of two to six days and then be released to the care of their treating physician. Each patient will receive a video visit once a day from a doctor and in-person visits from a nurse twice a day, or more if needed, according to the statement.

Other services available are infusion therapy; physiotherapy, occupational therapy and speech therapy; phlebotomy; mobile diagnostic services such as x-rays and echocardiograms; behavioral health care; and nutritional services. Other services, such as statistics laboratory, imaging and IV services, will be available in emergency situations and each patient will have a personal emergency response device, according to the release.

The program will be able to treat patients with heart failure, pneumonia, chronic obstructive pulmonary disease and cellulitis, among other conditions.